1. MARKETS
  2. SECTOR : COMMERCIAL SERVICES & SUPPLIES
  3. INDUSTRY : MISCELLANEOUS COMMERCIAL SERVICES
  4. STRUCTURE THERAPEUTICS INC - ADR

Structure Therapeutics Inc - ADR

XNAS: GPCR

Download real time

22.57 1.46 (6.92%)

64.03% Fall from 52W High

572.3K XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
11S
9W
0O
3T
1,294.2

Market Cap

Below industry Median
-10.6

PE TTM

Negative PE TTM
0.3

PEG TTM

PEG TTM is less than 1
1.5

Price to Book

Below industry Median
0.1

Beta 1Year

Very Low volatility


Insider Trading disclosures for Structure Therapeutics Inc - ADR

The latest disclosure was made by Blai Coll in Structure Therapeutics Inc - ADR where a trade of 363 American Depositary Shares done was reported to US exchanges on March 15, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Blai Coll Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 363 728 - - American Depositary Shares
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 826,890 826,890 - - Employee Stock Option (right to buy)
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 340,332 1,133,678 - 0 Ordinary Shares
Ashley F. Hall Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 124,032 124,032 - - Employee Stock Option (right to buy)
Ashley F. Hall Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 51,048 118,338 - 0 Ordinary Shares
Jun Yoon CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 821 2,115 - - American Depositary Shares
Jun Yoon CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 170,166 1,293,299 - 0 Ordinary Shares
Jun Yoon CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 413,445 413,445 - - Employee Stock Option (right to buy)
Xichen Lin CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 196,386 196,386 - - Employee Stock Option (right to buy)
Xichen Lin CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 80,829 166,536 - 0 Ordinary Shares
Yingli Ma CHIEF TECHNOLOGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 63,810 100,539 - 0 Ordinary Shares
Yingli Ma CHIEF TECHNOLOGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 155,040 155,040 - - Employee Stock Option (right to buy)
Blai Coll Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 116,988 219,588 - 0 Ordinary Shares
Blai Coll Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 284,241 284,241 - - Employee Stock Option (right to buy)
Jun Yoon CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2025 694 1,294 - - American Depositary Shares
Blai Coll Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2024 90,600 102,600 - 0 Ordinary Shares
Ashley F. Hall Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2024 82,890 82,890 - - Share option (right to buy)
Ashley F. Hall Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2024 67,290 67,290 - 0 Ordinary Shares
Blai Coll Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2024 111,000 111,000 - - Share option (right to buy)
Angus Charles Russell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2024 75,000 75,000 - - Share option (right to buy)
Joanne Waldstreicher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2024 37,500 37,500 - - Share Option (right to buy)
Daniel G. Welch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2024 37,500 37,500 - - Share Option (right to buy)
Ted W. Love Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2024 33,595 33,595 - - Share Option (right to buy)
Sharon E. Tetlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2024 37,500 37,500 - - Share Option (right to buy)
Eric L. Dobmeier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2024 37,500 37,500 - - Share Option (right to buy)
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.48 per share. 12 Jun 2024 50,001 793,346 - 0.5 24,000 Ordinary Shares
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2024 50,001 488,766 - - Share Option (right to buy)
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jun 2024 99,999 1 - - Share Option (right to buy)
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share. 12 Jun 2024 99,999 743,345 - 0.4 39,000 Ordinary Shares
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER 10 Jun 2024 555,000 643,346 - 0 Ordinary Shares
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER 10 Jun 2024 185,000 185,000 - - American Depositary Shares
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Jun 2024 185,000 0 - - American Depositary Shares
Xichen Lin CHIEF SCIENTIFIC OFFICER 03 Jun 2024 106,200 85,707 - 0 Ordinary Shares
Xichen Lin CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Jun 2024 17,700 0 - - American Depositary Shares
Xichen Lin CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. 03 Jun 2024 106,200 191,907 - 0.3 36,108 Ordinary Shares
Xichen Lin CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jun 2024 106,200 213,800 - - Share Option (right to buy)
Xichen Lin CHIEF SCIENTIFIC OFFICER 03 Jun 2024 35,400 35,400 - - American Depositary Shares
Xichen Lin CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Jun 2024 17,700 17,700 - - American Depositary Shares
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 335,481 335,481 - - Stock Option (right to buy)
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 134,682 1,198,346 - 0 Ordinary Shares
Mark Bach CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 65,352 65,352 - - Stock Option (right to buy)
Mark Bach CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 26,235 26,235 - 0 Ordinary Shares
Xichen Lin CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 85,707 85,707 - 0 Ordinary Shares
Xichen Lin CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 213,486 213,486 - - Stock Option (right to buy)
Yingli Ma CHIEF TECHNOLOGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 36,729 36,729 - 0 Ordinary Shares
Yingli Ma CHIEF TECHNOLOGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 91,494 91,494 - - Stock Option (right to buy)
Jun Yoon CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 148,134 148,134 - - Stock Option (right to buy)
Jun Yoon CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 59,469 1,123,133 - 0 Ordinary Shares
Raymond C. Stevens Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 335,481 335,481 - - Stock Option (right to buy)
Mark Bach CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 65,352 65,352 - - Stock Option (right to buy)
Jun Yoon CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 148,134 148,134 - - Stock Option (right to buy)
Xichen Lin CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 213,486 213,486 - - Stock Option (right to buy)
Yingli Ma CHIEF TECHNOLOGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 91,494 91,494 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters